309 related articles for article (PubMed ID: 12121564)
1. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
Kumar B; Saraswat A; Kaur I
Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
[TBL] [Abstract][Full Text] [Related]
2. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia.
Ng LC; Lee YY; Lee CK; Wong SM
Int J Dermatol; 2013 Jan; 52(1):102-5. PubMed ID: 23278617
[TBL] [Abstract][Full Text] [Related]
3. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
[TBL] [Abstract][Full Text] [Related]
4. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
van Dooren-Greebe RJ; Kuijpers AL; Termorshuizen F; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
[TBL] [Abstract][Full Text] [Related]
5. Short term methotrexate therapy in psoriasis.
Kumar B; Handa S; Kaur I
Indian J Med Res; 1994 Dec; 100():277-80. PubMed ID: 7829167
[TBL] [Abstract][Full Text] [Related]
6. Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Berends MA; Snoek J; de Jong EM; van de Kerkhof PC; van Oijen MG; van Krieken JH; Drenth JP
Aliment Pharmacol Ther; 2006 Sep; 24(5):805-11. PubMed ID: 16918884
[TBL] [Abstract][Full Text] [Related]
7. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
Nyfors A; Poulsen H
Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
Themido R; Loureiro M; Pecegueiro M; Brandão M; Campos MC
Acta Derm Venereol; 1992 Sep; 72(5):361-4. PubMed ID: 1361285
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients.
Cabello Zurita C; Grau Pérez M; Hernández Fernández CP; González Quesada A; Valerón Almazán P; Vilar Alejo J; Carretero Hernández G
J Dermatolog Treat; 2017 Aug; 28(5):401-405. PubMed ID: 28001499
[TBL] [Abstract][Full Text] [Related]
10. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
11. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
de Jong EM; Mørk NJ; Seijger MM; De La Brassine M; Lauharanta J; Jansen CT; Guilhou JJ; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber MR; Van De Kerkhof PC
Br J Dermatol; 2003 Feb; 148(2):318-25. PubMed ID: 12588386
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
[TBL] [Abstract][Full Text] [Related]
13. Detection of significant liver fibrosis in Chinese psoriasis patients receiving methotrexate: a comparison between transient elastography and liver histology.
Wong CSM; Mak LLY; Lee VKH; Lo RCL; Chung MMH; Chu F; Yeung CK; Yuen MF; Chan HHL
Hong Kong Med J; 2024 Apr; 30(2):110-119. PubMed ID: 38651202
[TBL] [Abstract][Full Text] [Related]
14. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate in childhood psoriasis.
Kumar B; Dhar S; Handa S; Kaur I
Pediatr Dermatol; 1994 Sep; 11(3):271-3. PubMed ID: 7971565
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
Dogra S; Krishna V; Kanwar AJ
Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
[TBL] [Abstract][Full Text] [Related]
17. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
[TBL] [Abstract][Full Text] [Related]
18. Systemic methotrexate therapy for psoriasis: past, present and future.
Dogra S; Mahajan R
Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
20. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
Radmanesh M; Rafiei B; Moosavi ZB; Sina N
Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
